We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZEK
1
DELISTED
The AZEK Co
AZEK
| $63.6M | 18.73% |
+1,170,131
| New | +$58.6M |
|
|
RDFN
2
DELISTED
Redfin
RDFN
| $40.6M | 11.97% |
+3,630,735
| New | +$35.6M |
|
|
3
Alphabet (Google) Class C
GOOG
$4.32T
| $9.16M | 2.7% |
+51,643
| New | +$8.53M |
|
|
4
Insmed
INSM
$23.3B
| $7.62M | 2.24% |
+75,728
| New | +$5.79M |
|
|
5
Sprouts Farmers Market
SFM
$6.93B
| $7.51M | 2.21% |
+45,609
| New | +$7.45M |
|
6
Carpenter Technology
CRS
$27.5B
| $6.74M | 1.99% |
+24,403
| New | +$5.32M |
|
7
Rocket Lab Corp
RKLB
$42.1B
| $6.08M | 1.79% |
170,038
+113,647
| +202% | +$2.78M |
|
8
Applovin
APP
$146B
| $5.93M | 1.75% |
+16,933
| New | +$5.49M |
|
9
FTAI Aviation
FTAI
$20.9B
| $5.21M | 1.54% |
+45,306
| New | +$5.07M |
|
10
Merck
MRK
$315B
| $5.09M | 1.5% |
64,345
+40,147
| +166% | +$3.19M |
|
11
SouthState Bank Corp
SSB
$10.2B
| $4.85M | 1.43% |
+52,711
| New | +$4.63M |
|
12
Applied Industrial Technologies
AIT
$12.3B
| $4.77M | 1.4% |
+20,501
| New | +$4.66M |
|
13
Mueller Industries
MLI
$13B
| $4.75M | 1.4% |
+119,440
| New | +$4.51M |
|
14
Chevron
CVX
$366B
| $4.21M | 1.24% |
29,388
-8,612
| -23% | -$1.21M |
|
|
PRMB
15
Primo Brands
PRMB
$9.21B
| $3.76M | 1.11% |
+126,995
| New | +$4.06M |
|
16
HCA Healthcare
HCA
$85.6B
| $3.71M | 1.09% |
9,681
+6,181
| +177% | +$2.23M |
|
17
Procter & Gamble
PG
$353B
| $3.41M | 1.01% |
21,421
+11,448
| +115% | +$1.87M |
|
18
Kroger
KR
$35.9B
| $3.27M | 0.96% |
+45,595
| New | +$3.15M |
|
19
EXL Service
EXLS
$4.38B
| $3.18M | 0.94% |
+72,708
| New | +$3.32M |
|
20
Revolution Medicines
RVMD
$38.1B
| $3.18M | 0.94% |
+86,510
| New | +$3.32M |
|
21
Progressive
PGR
$120B
| $3.1M | 0.91% |
+11,604
| New | +$3.18M |
|
22
Booking.com
BKNG
$143B
| $3.07M | 0.91% |
+13,275
| New | +$2.72M |
|
23
Halozyme
HALO
$9.2B
| $3.01M | 0.89% |
57,857
+48,294
| +505% | +$2.75M |
|
24
Pan American Silver
PAAS
$17.7B
| $2.96M | 0.87% |
+104,124
| New | +$2.69M |
|
25
Aflac
AFL
$62.6B
| $2.95M | 0.87% |
28,016
+19,716
| +238% | +$2.07M |
|
Similar funds
FS
HIIL
BC
PMAM
LFA
HAM
DP
SPC
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.